Heska Corporation (HSKA) Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP grew its holdings in shares of Heska Corporation (NASDAQ:HSKA) by 115.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 120,174 shares of the medical research company’s stock after purchasing an additional 64,418 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.70% of Heska Corporation worth $12,266,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Heska Corporation by 31.7% during the 2nd quarter. Vanguard Group Inc. now owns 461,841 shares of the medical research company’s stock valued at $47,141,000 after purchasing an additional 111,232 shares during the last quarter. Neuberger Berman Group LLC increased its holdings in Heska Corporation by 1.0% in the 2nd quarter. Neuberger Berman Group LLC now owns 449,574 shares of the medical research company’s stock worth $45,888,000 after acquiring an additional 4,329 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in Heska Corporation by 18.1% in the 2nd quarter. Russell Investments Group Ltd. now owns 225,388 shares of the medical research company’s stock worth $23,005,000 after acquiring an additional 34,594 shares during the last quarter. State Street Corp increased its holdings in Heska Corporation by 12.6% in the 1st quarter. State Street Corp now owns 173,917 shares of the medical research company’s stock worth $18,251,000 after acquiring an additional 19,408 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in Heska Corporation by 5.7% in the 2nd quarter. Northern Trust Corp now owns 120,060 shares of the medical research company’s stock worth $12,255,000 after acquiring an additional 6,517 shares during the last quarter. 78.58% of the stock is owned by hedge funds and other institutional investors.

In other Heska Corporation news, EVP Nancy Wisnewski sold 825 shares of Heska Corporation stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $102.21, for a total value of $84,323.25. Following the transaction, the executive vice president now directly owns 38,114 shares of the company’s stock, valued at approximately $3,895,631.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John Mcmahon sold 2,608 shares of Heska Corporation stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $101.17, for a total value of $263,851.36. Following the completion of the transaction, the chief financial officer now directly owns 193 shares in the company, valued at $19,525.81. The disclosure for this sale can be found here. 14.70% of the stock is owned by insiders.

Shares of Heska Corporation (NASDAQ:HSKA) opened at $84.68 on Wednesday. The firm has a market capitalization of $619.71, a P/E ratio of 44.79, a P/E/G ratio of 2.28 and a beta of 0.83. Heska Corporation has a 12-month low of $62.06 and a 12-month high of $115.00.

Heska Corporation (NASDAQ:HSKA) last released its earnings results on Thursday, November 2nd. The medical research company reported $0.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.03. The company had revenue of $31.40 million during the quarter, compared to the consensus estimate of $36.10 million. Heska Corporation had a return on equity of 15.35% and a net margin of 10.67%. Heska Corporation’s quarterly revenue was down 6.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 EPS. equities analysts forecast that Heska Corporation will post 2.03 earnings per share for the current year.

WARNING: “Heska Corporation (HSKA) Shares Bought by Dimensional Fund Advisors LP” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://sportsperspectives.com/2017/11/15/heska-corporation-hska-shares-bought-by-dimensional-fund-advisors-lp.html.

Several brokerages recently weighed in on HSKA. Aegis lifted their price objective on Heska Corporation from $114.50 to $129.50 and gave the stock a “buy” rating in a report on Tuesday, August 1st. B. Riley restated a “neutral” rating and issued a $85.00 target price on shares of Heska Corporation in a research note on Friday, July 28th. Benchmark Co. restated a “buy” rating and issued a $120.00 target price (up previously from $106.00) on shares of Heska Corporation in a research note on Wednesday, August 9th. BidaskClub upgraded Heska Corporation from a “hold” rating to a “buy” rating in a research note on Thursday, August 3rd. Finally, Zacks Investment Research upgraded Heska Corporation from a “hold” rating to a “buy” rating and set a $109.00 target price for the company in a research note on Friday, August 4th. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $106.25.

Heska Corporation Company Profile

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.

Want to see what other hedge funds are holding HSKA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heska Corporation (NASDAQ:HSKA).

Institutional Ownership by Quarter for Heska Corporation (NASDAQ:HSKA)

Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply